Left atrial thrombus resolution in atrial fibrillation or flutter: Results of a prospective study with rivaroxaban (X-TRA) and a retrospective observational registry providing baseline data (CLOT-AF)

American Heart Journal

Volumn 178, Issue , 2016, Pages 126-134

  Lip, Gregory Y H ^a,b   Hammerstingl, Christoph ^c   Marin, Francisco ^d   Cappato, Riccardo ^e   Meng, Isabelle Ling ^f   Kirsch, Bodo ^f   Van Eickels, Martin ^f   Cohen, Ariel ^g  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^b AALBORG UNIVERSITY   (Denmark)

^c UNIVERSITY HOSPITAL BONN   (Germany)

^d HOSPITAL UNIVERSITARIO VIRGEN DE LA ARRIXACA   (Spain)

^e HUMANITAS CLINICAL AND RESEARCH CENTER   (Italy)

^f BAYER PHARMA AG   (Germany)

^g SORBONNE UNIVERSITÉ   (France)

Author keywords

[No Author keywords available]

Indexed keywords

RIVAROXABAN; BLOOD CLOTTING FACTOR 10A INHIBITOR;

AGED; ANTICOAGULANT THERAPY; ARTICLE; ATRIAL FIBRILLATION; BLEEDING; BRADYCARDIA; CHRONIC KIDNEY FAILURE; EAR HEMORRHAGE; EASTERN EUROPEAN; FEMALE; GINGIVA BLEEDING; HEADACHE; HEALTH CARE QUALITY; HEART ATRIUM FLUTTER; HEART ATRIUM THROMBOSIS; HEART FAILURE; HUMAN; HYPERTHYROIDISM; INTENTION TO TREAT ANALYSIS; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NAUSEA; OBSERVATIONAL STUDY; PERIPHERAL EDEMA; PRIORITY JOURNAL; PROSPECTIVE STUDY; RETROSPECTIVE STUDY; THYROID TUMOR; TRANSESOPHAGEAL ECHOCARDIOGRAPHY; TREATMENT DURATION; COMPLICATION; DIAGNOSTIC IMAGING; HEART ATRIUM; HEART ATRIUM APPENDAGE; HEART DISEASES; MIDDLE AGED; REGISTER; THROMBOSIS; VERY ELDERLY;

AGED; AGED, 80 AND OVER; ATRIAL APPENDAGE; ATRIAL FIBRILLATION; ATRIAL FLUTTER; ECHOCARDIOGRAPHY, TRANSESOPHAGEAL; FACTOR XA INHIBITORS; FEMALE; HEART ATRIA; HEART DISEASES; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; REGISTRIES; RETROSPECTIVE STUDIES; RIVAROXABAN; THROMBOSIS;

EID: 84973324735     PISSN: 00028703     EISSN: 10976744     Source Type: Journal    
DOI: 10.1016/j.ahj.2016.05.007     Document Type: Article

References (28)

1. A.J. Camm, P. Kirchhof, G.Y.H. Lip, and et al. Guidelines for the management of atrial fibrillation: The Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC) Eur Heart J 31 2010 2369 2429
2. T. Watson, E. Shantsila, and G.Y.H. Lip Mechanisms of thrombogenesis in atrial fibrillation: Virchow's triad revisited Lancet 373 2009 155 166
3. N.M. Al Saady, O.A. Obel, and A.J. Camm Left atrial appendage: structure, function, and role in thromboembolism Heart 82 1999 547 554
4. I.W. Black, D. Fatkin, K.B. Sagar, and et al. Exclusion of atrial thrombus by transesophageal echocardiography does not preclude embolism after cardioversion of atrial fibrillation. A multicenter study Circulation 89 1994 2509 2513
5. A.L. Klein, R.D. Murray, and R.A. Grimm Role of transesophageal echocardiography-guided cardioversion of patients with atrial fibrillation J Am Coll Cardiol 37 2001 691 704
6. W.J. Manning, R.M. Weintraub, C.A. Waksmonski, and et al. Accuracy of transesophageal echocardiography for identifying left atrial thrombi. A prospective, intraoperative study Ann Intern Med 123 1995 817 822
7. V. Fuster, L.E. Rydén, D.S. Cannom, and et al. 2011 ACCF/AHA/HRS focused updates incorporated into the ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines Circulation 123 2011 e269 e367
8. B. Akdeniz, S. Türker, V. Öztürk, and et al. Cardioversion under the guidance of transesophageal echochardiograhy in persistent atrial fibrillation: results with low molecular weight heparin Int J Cardiol 98 2005 49 55
9. L.J. Collins, D.I. Silverman, P.S. Douglas, and et al. Cardioversion of nonrheumatic atrial fibrillation. Reduced thromboembolic complications with 4 weeks of precardioversion anticoagulation are related to atrial thrombus resolution Circulation 92 1995 160 163
10. G. Corrado, G. Tadeo, S. Beretta, and et al. Atrial thrombi resolution after prolonged anticoagulation in patients with atrial fibrillation Chest 115 1999 140 143
11. W.A. Jaber, D.L. Prior, M. Thamilarasan, and et al. Efficacy of anticoagulation in resolving left atrial and left atrial appendage thrombi: a transesophageal echocardiographic study Am Heart J 140 2000 150 156
12. M. Saeed, A. Rahman, A. Afzal, and et al. Role of transesophageal echocardiography guided cardioversion in patients with atrial fibrillation, previous left atrial thrombus and effective anticoagulation Int J Cardiol 113 2006 401 405
13. K. Seidl, M. Rameken, A. Drögemüller, and et al. Embolic events in patients with atrial fibrillation and effective anticoagulation: value of transesophageal echocardiography to guide direct-current cardioversion. Final results of the Ludwigshafen Observational Cardioversion Study J Am Coll Cardiol 39 2002 1436 1442
14. A.J. Camm, G.Y.H. Lip, R. De Caterina, and et al. 2012 Focused update of the ESC guidelines for the management of atrial fibrillation: an update of the 2010 ESC guidelines for the management of atrial fibrillation. Developed with the special contribution of the European Heart Rhythm Association Eur Heart J 33 2012 2719 2747
15. S. Fukuda, H. Watanabe, K. Shimada, and et al. Left atrial thrombus and prognosis after anticoagulation therapy in patients with atrial fibrillation J Cardiol 58 2011 266 277
16. J.P. Piccini, S.R. Stevens, Y. Lokhnygina, and et al. Outcomes following cardioversion and atrial fibrillation ablation in patients treated with rivaroxaban and warfarin in the ROCKET AF trial J Am Coll Cardiol 61 2013 1998 2006
17. S. Husted, R. De Caterina, F. Andreotti, and et al. Non-vitamin K antagonist oral anticoagulants (NOACs): no longer new or novel Thromb Haemost 111 2014 781 782
18. S. Dobashi, T. Fujino, and T. Ikeda Use of apixaban for an elderly patient with left atrial thrombus BMJ Case Rep 2014 2014 10.1136/bcr-2014-203870
19. C. Hammerstingl, B. Pötzsch, and G. Nickenig Resolution of giant left atrial appendage thrombus with rivaroxaban Thromb Haemost 109 2013 583 584
20. T. Kawakami, H. Kobayakawa, H. Ohno, and et al. Resolution of left atrial appendage thrombus with apixaban Thromb J 11 2013 26
21. J. Takasugi, H. Yamagami, T. Okata, and et al. Dissolution of the left atrial appendage thrombus with rivaroxaban therapy Cerebrovasc Dis 36 2013 322 323
22. A. Vidal, and G. Vanerio Dabigatran and left atrial appendage thrombus J Thromb Thrombolysis 34 2012 545 547
23. G.Y.H. Lip, C. Hammerstingl, F. Marin, and et al. Rationale and design of a study exploring the efficacy of once-daily oral rivaroxaban (X-TRA) on the outcome of left atrial/left atrial appendage thrombus in nonvalvular atrial fibrillation or atrial flutter and a retrospective observational registry providing baseline data (CLOT-AF) Am Heart J 169 2015 464 471
24. S. Schulman, and C. Kearon Definition of major bleeding in clinical investigations of antihemostatic medicinal products in non-surgical patients J Thromb Haemost 3 2005 692 694
25. M. Ferner, D. Wachtlin, T. Konrad, and et al. Rationale and design of the RE-LATED AF-AFNET 7 trial: REsolution of Left atrial-Appendage Thrombus - Effects of Dabigatran in patients with Atrial Fibrillation Clin Res Cardiol 105 2016 29 36
26. P. Bernhardt, H. Schmidt, C. Hammerstingl, and et al. Fate of left atrial thrombi in patients with atrial fibrillation determined by transesophageal echocardiography and cerebral magnetic resonance imaging Am J Cardiol 94 2004 801 804
27. A.J. Camm, P. Amarenco, S. Haas, and et al. XANTUS: a real-world, prospective, observational study of patients treated with rivaroxaban for stroke prevention in atrial fibrillation Eur Heart J 2015 10.1093/eurheartj/ehv466
28. M.R. Patel, K.W. Mahaffey, J. Garg, and et al. Rivaroxaban versus warfarin in nonvalvular atrial fibrillation N Engl J Med 365 2011 883 891